Alaunos Therapeutics, Inc. (TCRT) earnings
TCRT earnings moved a median of -3.07% by the close. Quarterly and annual TCRT reports and results, each read against the price at its own news timestamp. Back to the TCRT overview →
15 measured TCRT earnings events.
Where these TCRT earnings landedvs 15 measured TCRT earnings reactions
| Middle 50% of TCRT earnings reactions | -7.29% to -0.57% |
|---|---|
| Median reaction (to close) | -3.07% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 TCRT earnings events with a measured close landed between -7.29% and -0.57%; 20% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -2.44% | -6.83% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -0.80% | |
| Form 10-K/A Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.39% | +1.95% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | -0.34% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.09% | +7.69% | |
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.42% | -6.25% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -1.02% | -3.07% | |
| Form 10-K/A Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -7.82% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +50.00% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -1.78% | |
| Form 10-Q Alaunos Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | — | -2.89% | |
| Form 10-Q Alaunos Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.65% | -7.75% | |
| Form 10-K Alaunos Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -3.31% | |
| Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives | Press release | -3.19% | -18.26% | |
| Form 10-Q Alaunos Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -3.19% | -18.26% |
Keep exploring
More TCRT: analyst actions → · SEC filings → · TCRT overview →